| Literature DB >> 32660127 |
Michał Staniak1, Magdalena Wójciak1, Ireneusz Sowa1, Katarzyna Tyszczuk-Rotko2, Maciej Strzemski1, Sławomir Dresler3, Wojciech Myśliński4.
Abstract
Monolithic fillings used in chromatography are of great interest among scientists since the first reports of their synthesis and use were published. In the 20 years since silica-based monolithic columns were introduced into the commercial market, numerous papers describing their chromatographical properties and utility in various branches of industry and scientific investigations were presented. This review is focused on possible applications of commercially available silica-based HPLC monolithic columns in the analysis of biological samples.Entities:
Keywords: drug analysis; monolithic column; plant analysis; stationary phases in HPLC
Mesh:
Substances:
Year: 2020 PMID: 32660127 PMCID: PMC7397265 DOI: 10.3390/molecules25143149
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Application of Chromolith® Performance RP 18-e (100 × 4.6 mm inner diameter (i.d.)) in analysis of plant samples.
| Sample/Analytes | Part of Plant/Matrix | Type of Elution/Mobile Phase | Conditions | Detector | Ref. |
|---|---|---|---|---|---|
| orientin, isovitexin, vitexin, | tincture from | gradient elution/ | 1.0 mL/min/30 °C/one column | PDA | [ |
| polyacetylenes and polyenes | roots from | gradient elution/ | 2.0 mL/min/20 °C/one column | PDA | [ |
| (fingerprinting) | gradient elution/ | 1.0 mL/min/35 °C/four columns | DAD | [ | |
| catechins and caffeine | tea samples | isocratic elution/ | 1.4 mL/min/-/one column | UV | [ |
| quercetin, naringenin, naringin, myricetin, rutin, kaempferol | tomatoes | isocratic elution/ | 1.0 mL/min/25 °C/one column | A: UV | [ |
| gallic acid, protocatechuic aldehyde, gentisic acid, catechin, vanillinic acid, caffeic acid, vanillin, epicatechin, syringaldehyde, p-coumaric acid, | musts from grapes: Riesling and Monastrell | gradient elution/ | 2.5 mL/min/25 °C/one column | PDA and FL | [ |
| catechin, epicatechin, quercetin, kaempferol, apigenin, fisetin, morin, naringenin, hesperetin, chrysin | green tea, red wine, orange, propolis and | gradient elution/ | 2.0 mL/min/25 °C/one column | DAD | [ |
| (fingerprinting) | aerial parts from | gradient elution/ | 1.0 mL/min/25 °C/two columns | UV | [ |
| gastrodin |
| gradient elution/H2O/ACN | 1.0 mL/min/-/one column | DAD | [ |
| echitamine, N-demethylalstogustine, loganetin | stem, stem bark, root, root bark, fruits, leaves from | isocratic elution/ | 0.5 mL/min/25 °C/two columns | DAD | [ |
| oroxylin A, chrysin, | roots from | isocratic elution/ACN/H2O | 1.0 mL/min/30 °C/one column | PDA | [ |
| 6-gingerol, 8-gingerol, | rhizome from | gradient elution/ | 3.0 mL/min/room temp./one column | PDA | [ |
| schizandrin, gomisin A, | callus from | isocratic elution/ | 2.0 mL/min/-/one column | PDA | [ |
| bacopaside I, bacoside A3, bacopaside II, bacopaside X, bacopasaponin C, apigenin | herbs of | isocratic elution/ | 0.7 mL/min/25 °C/one column | ELSD | [ |
| vanillin, vanillic acid, | pods from | isocratic elution/ | 4.0 mL/min/35 °C/one column | PDA | [ |
| furocoumarins: | fruits from | gradient elution/ | 0.5 mL/min/-/one column | PDA | [ |
| tannins and polyphenols | commercial products | gradient elution/ACN/H2O | 2.5 mL/min/-/one column | UV | [ |
| phenolic acids: vanillic, gallic, syringic, | plum fruits | gradient elution/ | 1.0 mL/min/-/one column | DAD | [ |
| niaziridin and niazirin | leaves, pods, and bark from | isocratic elution/ | 0.7 mL/min/25 °C/one column | PDA | [ |
| A. fatty acid methyl esters | --- | isocratic elution/ | 2.0 mL/min/25 °C/two columns | A. radioisotope detector | [ |
| iridoid glycosides: harpagoside and | extracts from | gradient elution/ | 5.0 mL/min/30 °C/two columns | PDA | [ |
| harpagoside, acetoside, cinnamic acid, 8- | root tubers | gradient elution/ | 5.0 mL/min/30 °C/two columns | PDA | [ |
| curcuminoids: curcumin, | herbal medicament | isocratic elution/ | 1.0 mL/min/-/one column | UV–Vis | [ |
| rutin | Buckwheat Tea and seeds from | isocratic elution/MeOH/H2O (5:5, | 1.5 mL/min/30 °C/one column | UV–Vis | [ |
| glycyrrhizic and glycyrrhetinic acids | roots from | gradient elution/H2O/ACN | 2.5 mL/min/room temp./one column | PDA | [ |
| reserpine, ajmaline, ajmalicine | roots from | gradient elution/ | 1.0 mL/min/26 °C/one column | PDA | [ |
| myricetin, quercetin, kaempferol | fruits and leaves from | isocratic elution/ACN/10 mM potassium dihydrogen orthophosphate buffer (pH = 3.0) (38:62, | 4.0 mL/min/40 °C/one column | PDA | [ |
| allosecurinine, securinine | biomasses from | gradient elution/H2O/ACN | 1.0 mL/min/25 °C/one column | PDA | [ |
| proanthocyanidins | pea from | gradient elution/ | 3.0 mL/min/30 °C/two columns | DAD | [ |
| gallic acid, (+)-catechin, chlorogenic acid, procyanidin B2, | fresh peel or pulp from | gradient elution/ | 2.5 mL/min/25 °C/one column | PDA | [ |
| capsaicinoids: nordihydrocapsaicin, capsaicin, dihydrocapsaicin, homocapsaicin, homodihydro-capsaicin | peppers | gradient elution/ | 6.0 mL/min/30 °C/one column | FL | [ |
| anthocyanins | red cabbage | gradient elution/ | 4.0 mL/min/27 °C/one column | DAD | [ |
| protopine, allocryptopine, berberine, chelidonine, chelerythrine, sanguinarine, coptisine | roots from | gradient elution/ | 2.0 mL/min/25 °C/three columns | DAD | [ |
| vincristine, vinblastine, | leaves from | isocratic elution/ACN/0.1 M phosphate buffer containing 0.5% glacial acetic acid (pH = 3.5), (21:79, | 1.2 mL/min/25 °C/one column | PDA | [ |
| gallic acid, protocatechuic acid, | aerial part from | gradient elution/ | 2.0 mL/min/26 °C/one column | DAD | [ |
| proanthocyanidins cleavage products | hop cones from | gradient elution/H2O/ACN | 3.0 mL/min/30 °C/two columns | DAD | [ |
| daidzin, gycitin, genistin, acetyldaidzin, acetylglycitin, daidzein, glycitein, acetylgenistin, genistein | extracts from | gradient elution/ | flow gradient 3.0 mL and 4.0 mL/min/ two columns | DAD | [ |
| α-amyrin, α -amyrin acetate, β-amyrin, β-amyrin acetate, lupeol, lupeol acetate | flowers, leaves, roots and stems from five species of | isocratic elution/ACN/H2O (95:5, | 2.0 mL/min/25 °C/one column | PDA | [ |
| daidzin, glycitin, genistin, malonyl daidzin, malonyl glycitin, malonyl genistin, daidzein, glycitein, genistein | extracts from soybeans | gradient elution/MeOH/H2O | 0.8 mL/min/-/two columns | PDA | [ |
| wine samples | gradient elution/ | gradient flow 4.0 mL and 7.0 mL/min/two columns | PDA | [ | |
| lysergol and chanoclavine | seeds from | isocratic elution/ | 1.0 mL/min/25 °C/one column | PDA | [ |
| rutin, isorhamnetine-3- | berries from | gradient elution/H2O/ACN | 3.0 mL/min/40 °C/one column | UV | [ |
| geraniin, ellagic acid, gallic acid | rind from | isocratic elution/ACN/H2O (30:70, | 0.5 mL/min/room temp./one column | UV–Vis | [ |
| (fingerprinting) | gradient elution/ | 1.0 mL/min/35 °C/two columns | UV–ELS | [ | |
| carnosic acid, carnosol, | leaves from | binary gradient/ACN–H2O–H3PO4 | 1.5 mL/min/-/one column | UV–Vis | [ |
| α-solanine and α-chaconine | potato tubers | isocratic elution/20 mM phosphate buffer (pH = 7.8)/ACN (65:35, | 0.6 mL/min/-/one column | CL | [ |
a MeOH- methanol; b ACN- acetonitrile; c THF- tetrachedrofurane; d TFA- trifluoroacetic acid.
Chromolith® Performance RP 18-e 100 × 4.6 mm in analysis of drugs in various matrices.
| Name of Drug | Matrix | Type of Elution/Mobile Phase | Conditions | Detector | Ref. |
|---|---|---|---|---|---|
| raltegravir | human plasma | isocratic elution/10 mM ammonium formate in water (pH = 3.0)/ACN b (3:7, | 1.2 mL/min/40 °C/one column | MS/MS | [ |
| amphotericin B | human plasma | gradient elution/ | 1.8 mL/min/-/one column | MS/MS | [ |
| lamivudine | human plasma | isocratic elution/ | 1.5 mL/min/20 °C/one column | UV | [ |
| mirtazapine and metabolites: | human plasma | isocratic elution/ | 2.0 mL/min/-/one column | FL | [ |
| montelukast and fexofenadine | human plasma | isocratic elution/ | 1.2 mL/min/5 °C/one column | MS/MS | [ |
| clonazepam, diazepam, flunitrazepam, lorazepam, midazolam, | whole blood samples | isocratic elution/ | 1.5 mL/min/-/one column | MS | [ |
| furosemide and norfloxacin | human plasma | isocratic elution/ | 3.0 mL/min/25 °C/one column | FL | [ |
| omeprazole | human plasma | isocratic elution/ | 1.5 mL/min/-/one column | UV | [ |
| cefadroxil, cefaclor, cephalexin, cefotaxime, cefazolin, cefuroxime, cefoperazone and ceftiofur | milk | gradient elution/ | 1.5 mL/min/-/one column | PDA | [ |
| pantoprazole | human plasma | isocratic elution/ | 1.5 mL/min/-/one column | UV | [ |
| codeine | human plasma | isocratic elution/ | 1.0 mL/min/25 °C/one column | MS/MS | [ |
| pioglitazone | human serum and urine | isocratic elution/ | 2.0 mL/min/-/one column | DAD | [ |
| diazepam, clonazepam, | whole blood | isocratic elution/ | 2.0 mL/min/-/one column | DAD | [ |
| nimesulid and major metabolite | human plasma | isocratic elution/ | 1.5 mL/min/25 °C/one column | DAD | [ |
| chloramphenicol | human blood | isocratic elution/ | 1.5 mL/min/28 °C/one column | UV–Vis | [ |
a MeOH- methanol; b ACN- acetonitrile.
Chromolith® High Resolution RP 18-e 100 × 4.6 mm in analysis of active compounds in various matrices.
| Active Compound/Drug | Matrix | Type of Elution/Mobile Phase | Conditions | Detector | Ref. |
|---|---|---|---|---|---|
| retinol and α-tocopherol | serum and human breast milk | 100% MeOH a | 1.5 mL/min/50 °C/one column | FL | [ |
| terpenoids and flavonoid aglycones | aerial parts from | gradient elution/H2O/MeOH | 1.0 mL/min/32 °C/one column | UV | [ |
| rutin, piceatannol, resveratrol, naringenin, kaempferol, emodin, physcion | root, stem and leaf from five species of | gradient elution/ | 0.4 mL/min/room temp./one column | MS | [ |
| avanafil and its degradation products | pharmaceutical preparation | isocratic elution/H2O/ACN | 0.5 mL/min/40 °C and 15 °C/one column | DAD, | [ |
| vitamins K3, D3, E, and A | capsules and | isocratic elution/ACN/MeOH | 4.0 mL/min/room temp./one column | DAD | [ |
| metformin, linagliptin, sitagliptin, vildagliptin | human plasma | isocratic elution/ | 0.4 mL/min/20 °C/one column | MS/MS | [ |
| aspirin and dipyridamole | human plasma | isocratic elution/MeOH/0.1% formic acid in H2O (90:10, | 1.0 mL/min/-/one column | MS/MS | [ |
| irbesartan and hydrochlorothiazide | tablets and urine | gradient elution/ | flow gradient: 0.8 mL and 1.5 mL/min/40 °C/one column | DAD | [ |
| dapsone and | human plasma | isocratic elution/ACN/2 mM ammonium acetate in H2O (90:10, | 0.8 mL/min/-/one column | MS/MS | [ |
a MeOH- methanol; b ACN- acetonitrile.